Alpha Windward’s Myriad Genetics MYGN Stock Holding History

Alpha Windward’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-232	Closed	-$8K	–	451
2015 Q1	$8K	Hold	232	–	–	0.01%	402
2014 Q4	$8K	Sell	232 -530	-70%	-$18.8K	0.01%	386
2014 Q3	$29K	Hold	762	–	–	0.02%	326
2014 Q2	$30K	Buy	+762	New	+$28.4K	0.02%	318

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alpha Windward's MYGN Position: Q2 2015 in Review

Alpha Windward sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 232 shares — an estimated $8K sold.

Alpha Windward first reported a position in MYGN in Q2 2014 and held it in 4 quarters. The position peaked at $30K in Q2 2014. 234 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

Alpha Windward reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
Alpha Windward sold 232 Myriad Genetics shares in Q2 2015, an estimated $8K.
Alpha Windward first reported a position in Myriad Genetics in Q2 2014 and held it in 4 quarters.
Alpha Windward's Myriad Genetics position peaked at $30K in Q2 2014.
234 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Alpha Windward's 13F filing for Q2 2015, filed 8 Jul 2015.